8,006 results match your criteria: "Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis"

Life-threatening dermatoses.

Clin Dermatol

December 2024

Department of Dermatology, Yale University School of Medicine, New Haven, CT. Electronic address:

While rare, life-threatening dermatoses encompass various inflammatory, infectious, vasculitic/vasculopathy, paraneoplastic, and neoplastic skin diseases. Complications include skin barrier dysfunction, secondary infection, and internal organ involvement. Skin signs may serve as a critical window into systemic disease.

View Article and Find Full Text PDF

Toxic epidermal necrolysis (TEN) is a severe skin reaction caused by extensive epidermal and mucosal necrosis. This clinical phenomenon is known as an acute syndrome of apoptotic pan-epidermolysis (ASAP). The ASAP phenomenon is observed in conditions that mimic TEN, highlighting the challenge in distinguishing these conditions.

View Article and Find Full Text PDF

Amidst worldwide reports of adverse oral lesions subsequent to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, the current systematic review planned to determine the prevalence of adverse oral events in adult individuals (≥18 years) after SARS-CoV-2 vaccination, emphasizing upon the type and dose of vaccine, time of onset, and underlying pathophysiology. The registered protocol (PROSPERO CRD42023421307), conforming with PRISMA guidelines, included an all-inclusive literature search through online databases, consisting of Scopus, PubMed/MEDLINE, Web of Science, Lilacs, Livivo, and PROSPERO, completed on 2 May 2023, followed by assessment of risk of bias by Joana Briggs Institute Evaluation Checklist. Due to the paucity of literature, case reports and case series were included.

View Article and Find Full Text PDF

Introduction: Cutaneous immune-mediated adverse drug reactions are more prevalent in people with human immunodeficiency virus (PWH). Severe cutaneous adverse drug reactions (SCAR) are a life-threatening subset of cutaneous adverse drug reactions (CADRs) and a significant public health issue in settings endemic for human immunodeficiency virus and tuberculosis. However, limited data are available on CADR requiring hospitalisation in African settings.

View Article and Find Full Text PDF

Purpose: To investigate the rare side effects of Osimertinib in a case of toxic epidermal necrosis.

Case Presentation: We report on a case of a 44-year old woman with lung adenocarcinoma harboring an EGFR-sensitizing mutation who was treated with Osimertinib as the second-line treatment. Ten days after Osimertinib initiation, a diffuse erythematous rash rapidly spread over the patient's trunk along with vesicles and purpuric macules; furthermore, she developed erythema and exfoliation on the face and trunk and severe mucositis.

View Article and Find Full Text PDF

Vancomycin and linezolid: severe cutaneous adverse reactions to drugs.

Expert Opin Drug Saf

December 2024

Department of Pharmacy, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Background: Severe cutaneous adverse reactions (SCARs), including Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), and Acute Generalized Exanthematous Pustulosis (AGEP), pose significant therapeutic challenges. Vancomycin and linezolid have been linked to these life-threatening conditions, necessitating a better understanding of their associated risks.

Methods: We conducted a retrospective analysis using data from the FDA Adverse Event Reporting System (FAERS) database.

View Article and Find Full Text PDF
Article Synopsis
  • Enfortumab vedotin combined with pembrolizumab (EV+P) shows effectiveness in treating metastatic urothelial carcinoma, but can lead to severe skin reactions like Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).
  • A case is presented of a 67-year-old man who developed SJS/TEN overlap after EV+P therapy, demonstrating the importance of recognizing and treating severe skin toxicities early in patients with additional health issues.
  • Effective management requires quick action with steroids and a multidisciplinary approach, alongside vigilant monitoring and reporting of adverse effects to enhance patient safety.
View Article and Find Full Text PDF
Article Synopsis
  • A 10-year-old boy developed severe toxic epidermal necrolysis due to trimethoprim-sulfamethoxazole and was successfully treated with a multi-targeted therapy approach.
  • The treatment team included specialists from pediatrics, dermatology, otolaryngology, urology, wound care, pain management, dietetics, and psychology, demonstrating a comprehensive care model.
  • Key interventions included intravenous immunoglobulin, steroids, cyclosporin A for eye issues, amniotic membrane transplantation, and etanercept for steroid management, leading to recovery without side effects by day 13.
View Article and Find Full Text PDF

A 33-year-old female presented with coryzal symptoms, facial swelling, severe haemorrhagic stomatitis, blistering oral mucositis, conjunctival injection and a sparse targetoid rash on the back and face, requiring admission to hospital. She had received the seasonal influenza vaccination 3 days prior to feeling unwell. Differential diagnosis included erythema multiforme major (EMM) secondary to the influenza vaccine or Mycoplasma pneumoniae-induced rash and mucositis (MIRM).

View Article and Find Full Text PDF
Article Synopsis
  • Superficial mucoceles (SM) are benign, small vesicles in the oral mucosa caused by salivary gland duct rupture, often found on the lower lip.
  • Immune checkpoint blockade treatments used in cancer can lead to skin-related side effects in 40-50% of patients, with severe cases occurring in 1-2%, such as Stevens-Johnson syndrome.
  • A case study highlighted the successful treatment of multiple SM in a patient with squamous cell carcinoma, utilizing plasma and electrocoagulation methods, and aimed to improve understanding of mucosal reactions to cancer therapies.
View Article and Find Full Text PDF

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe mucocutaneous reactions, often triggered by medications, characterized by blistering and epithelial sloughing. We report the case of a 66-year-old male who presented with a 2-day history of fluid-filled lesions on his body. On examination, erosions were observed on the posterior and anterior trunk, as well as on both upper and lower limbs.

View Article and Find Full Text PDF

Anti-Cancer Drug-Induced Lyell's Syndrome: A Series of Two Patients.

Curr Oncol

November 2024

Institut du Cancer Avignon Provence, 250 Chemin de Baigne-Pieds, 84000 Avignon, France.

Article Synopsis
  • Lyell's syndrome, also known as Toxic Epidermal Necrolysis (TEN), is a severe skin condition primarily caused by an allergic reaction to medications.* -
  • Recent developments in cancer treatments, such as targeted therapy and immunotherapy, are increasingly linked to cases of Lyell's syndrome, although traditional anti-cancer drugs were less frequently associated.* -
  • Two case studies illustrate TEN occurring in patients undergoing treatment for metastatic cancers with new therapies; unfortunately, both patients succumbed to the condition despite prompt medical intervention.*
View Article and Find Full Text PDF

Erythema multiforme (EM) is an immune-mediated condition that manifests as targetoid skin lesions and can be triggered by various factors, including infections and vaccinations. This case report describes a 41-day-old full-term male infant who developed widespread annular, bullseye-shaped erythematous skin lesions one week after receiving the Bacillus Calmette-Guérin (BCG) vaccination. The infant, exclusively breastfed and without a significant past medical history, presented with these lesions but no associated systemic symptoms.

View Article and Find Full Text PDF

Erythema multiforme.

EClinicalMedicine

November 2024

GrIDIST (Groupe Infectiologie et Infections Sexuellement Transmissibles) Working Group of the French Society of Dermatology, France.

Article Synopsis
View Article and Find Full Text PDF

Post-Stevens-Johnson Syndrome Bronchiolitis Obliterans: Report of a Complex Case and a Literature Review.

Cureus

November 2024

Respiratory Medicine, Dartford and Gravesham National Health Service (NHS) Trust, Dartford, GBR.

Article Synopsis
View Article and Find Full Text PDF
Article Synopsis
  • - Severe cutaneous adverse reactions (SCARs) like AGEP, DRESS, SJS, and TEN are serious conditions associated with high mortality rates, and while corticosteroids are commonly used for treatment, their effectiveness is uncertain due to infection risks.
  • - Recent studies have introduced TNF-α inhibitors, which have shown promise in treating SCARs, with a report indicating that four patients (21-54 years old) treated with these inhibitors had successful recoveries without complications.
  • - The TNF-α inhibitors work by targeting the harmful immune response linked to SCARs, but more large-scale trials are needed to confirm their efficacy and ensure a safe approach to their use.
View Article and Find Full Text PDF